FDA Adapts Enforcement Strategy In Increasingly Globalized Market
This article was originally published in The Rose Sheet
Executive Summary
FDA will overhaul its enforcement approach to reflect the impact of globalization by partnering more with foreign counterparts, streamlining inspections, recalls and emergency responses and using stiff criminal sanctions to deter noncompliance, FDA officials say.